title: Evidence for medial-mass regression in the vascular wall of Dahl hypertensive rats by cicletanine treatment.
abstract: We designed experiments to investigate the effects of cicletanine, a novel antihypertensive drug, on medial hypertrophy in Dahl rats susceptible to salt-induced hypertension (Dahl S rats). Cicletanine treatment (500 mg of cicletanine/kg of chow) for 6 weeks lowered blood pressure by 19% in Dahl S rats challenged with a high-salt (4%) diet. The blood pressure reduction was associated with a significant decrease in weight of the aortic vessels. Morphological examination revealed that this treatment decreased medial hypertrophy and expansion of intimal tissue, in concert with resolution of the periarteritis in the intrarenal arteries. In fact, the content of actin in the aortic wall, analyzed by SDS-PAGE, was decreased significantly with this treatment and myosin content was reduced to the same extent as well. Moreover, cicletanine per se lowered protein synthesis in randomly cycling cultured vascular smooth muscle cells (VSMCs) from Sprague-Dawley rats. Actin formation by VSMCs was decreased with cicletanine. Thus, these data indicate that chronic cicletanine treatment produces regression of the medial hypertrophy in Dahl S rats. Direct inhibitory effects on cytoskeleton protein synthesis, as well as its antihypertensive action, are partly responsible for this regression in vivo.
authors.affiliation: 2nd Department of Medicine, University of Tokyo, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Uehara
authors.forename: A
authors.initials: A
authors.lastname: Numabe
authors.forename: Y
authors.initials: Y
authors.lastname: Kawabata
authors.forename: T
authors.initials: T
authors.lastname: Nagata
authors.forename: J
authors.initials: J
authors.lastname: Iwai
authors.forename: H
authors.initials: H
authors.lastname: Matsuoka
authors.forename: S
authors.initials: S
authors.lastname: Yagi
authors.forename: Y
authors.initials: Y
authors.lastname: Takabatake
authors.forename: T
authors.initials: T
authors.lastname: Sugimoto
mesh_terms: D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001011:Aorta / Q000378:metabolism; D002478:Cells, Cultured; D004232:Diuretics / Q000097:blood / Q000494:pharmacology* / Q000652:urine; D004591:Electrophoresis, Polyacrylamide Gel; D006973:Hypertension / Q000139:chemically induced / Q000235:genetics / Q000503:physiopathology*; D066298:In Vitro Techniques; D007202:Indicators and Reagents; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D009218:Myosins / Q000378:metabolism; D014176:Protein Biosynthesis; D011725:Pyridines; D051381:Rats; D011919:Rats, Inbred Strains; D012077:Renal Artery / Q000378:metabolism; D012965:Sodium Chloride
chemical_list: D000889:Anti-Arrhythmia Agents; D004232:Diuretics; D007202:Indicators and Reagents; D011725:Pyridines; D012965:Sodium Chloride; C038068:cicletanine; D009218:Myosins